Sientra Inc
F:S0Z
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aditya Birla Capital Ltd
NSE:ABCAPITAL
|
IN |
Sientra Inc
Total Current Liabilities
Sientra Inc
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Sientra Inc
F:S0Z
|
Total Current Liabilities
$152.1m
|
CAGR 3-Years
39%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
|
Haemonetics Corp
NYSE:HAE
|
Total Current Liabilities
$539.9m
|
CAGR 3-Years
34%
|
CAGR 5-Years
23%
|
CAGR 10-Years
12%
|
|
|
ICU Medical Inc
NASDAQ:ICUI
|
Total Current Liabilities
$498.9m
|
CAGR 3-Years
0%
|
CAGR 5-Years
21%
|
CAGR 10-Years
28%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Total Current Liabilities
$1.9B
|
CAGR 3-Years
0%
|
CAGR 5-Years
8%
|
CAGR 10-Years
22%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Total Current Liabilities
$333.4m
|
CAGR 3-Years
10%
|
CAGR 5-Years
33%
|
CAGR 10-Years
25%
|
|
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Total Current Liabilities
$239.8m
|
CAGR 3-Years
3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
11%
|
|
Sientra Inc
Glance View
Sientra, Inc. operates as a medical aesthetics company, which engages in developing and commercializing plastic surgery implantable devices. The company is headquartered in Santa Barbara, California and currently employs 319 full-time employees. The company went IPO on 2014-10-29. The firm's primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures. The firm sells its breast implants and breast tissue expanders, or breast products to plastic surgeons. Its breast implants are primarily used in elective procedures, which are generally performed on a cash-pay basis. Implant Texture provides texturing on the implant shell that is designed to reduce the incidence of malposition, rotation and capsular contracture. The firm also offers breast tissue expanders for reconstruction procedures predominantly to hospitals and surgery centers, and its BIOCORNEUM scar management products to plastic surgeons, dermatologists and other specialties. The firm's brands also include Platinum20, Sientra Smooth, Sientra Teardrop, Allox, Allox2, Anatomical Controlled, BIOCORNEUM, Curve, Luxe, Softspan, Silishield and AuraG.
See Also
What is Sientra Inc's Total Current Liabilities?
Total Current Liabilities
152.1m
USD
Based on the financial report for Sep 30, 2023, Sientra Inc's Total Current Liabilities amounts to 152.1m USD.
What is Sientra Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
23%
Over the last year, the Total Current Liabilities growth was 87%. The average annual Total Current Liabilities growth rates for Sientra Inc have been 39% over the past three years , 23% over the past five years .